2024 University of Kansas Cancer Center Breast Cancer Year in Review

Learn How to Claim Your Credit

Click here to view on-demand content

For forty-six years, the San Antonio Breast Cancer Symposium’s mission has been to provide state-of-the-art information on breast cancer research. The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of the SABCS meeting held in December and it gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees.

Event Page

Accreditation Information | 4.00

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

• Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.

• Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• Learners Notification

  Acknowledgement of Financial Commercial Support
  No financial commercial support was received for this educational activity.

  Acknowledgement of In-Kind Commercial Support
  No in-kind commercial support was received for this educational activity.

  Satisfactory Completion
  Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

  Joint Accreditation Statement
  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  ​Physicians
  Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists
  Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.
  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  Nurses
  Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.

  Objectives - After Attending This Program You Should Be Able To
  Determine best application of new targeted therapies in patients with early-stage and metastatic disease

  Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer

  Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.

  Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC. Outline the clinical trial data on the use of

  Disclosure of Conflict of Interest
  The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

How to Get Your Certificate

For ACCME, ANCC, ACPE Click on the "Claim Your CME Credit" link blow

1. Evaluate the meeting.

2. Print, download, or save your certificate for your records.

3. Questions? Email Certificate@AmedcoEmail.com